Saturday, July 11, 2026

Drug profile · INN

y150

y150 is an FDA-listed pharmaceutical active ingredient.

NMPA: clinical trials
Patents linked 0
Pipeline programs 2
News articles 0
Drug details — y150
Class
Route
Patents
0
Programs
2
Data quality
0.70

Quick answer

y150 is an FDA-listed pharmaceutical active ingredient.

Key facts

INN y150

Approval history

Authority Status Date
NMPA clinical trials

Pipeline programs

  1. Sotagliflozin Phase 2 · LEXICON PHARMACEUTICALS · Cardiac Failure Aggravated
  2. Y150 Phase 1 · Wuhan YZY Biopharma · Relapsed or Refractory Multiple Myeloma

Frequently asked questions

What is y150?

y150 is an FDA-listed pharmaceutical active ingredient.